Gentronix, Apredica to Collaborate on Predictive Toxicology | GenomeWeb

NEW YORK (GenomeWeb News) – Gentronix and Apredica said today that they will collaborate on providing drug-discovery support services with a focus on predictive toxicology.

Watertown, Mass.-based Apredica is an ADME-Tox contract research laboratory and has been working with Gentronix on developing "a joint predictive toxicology offering based on a set of assays that accurately predict many known mechanisms of human toxicities," the firm's president, Katya Tsaioun, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.